1 |
Anti-RhD antibody therapy modulates human natural killer cell function.
61
|
Elias S...Mandelboim O
|
32467141 |
2020 |
2 |
IgG3 anti-Kell allotypic variation results in differential antigen binding and phagocytosis.
61
|
Cen SY...Branch DR
|
31930726 |
2020 |
3 |
Impact of intrauterine transfusion on fetal coagulation physiology by thromboelastography.
61
|
Emery SP...Waters JH
|
31994748 |
2020 |
4 |
Frequency and clinical significance of red cell antibodies in pregnancy - A prospective study from India.
61
|
Das S...Baliga PB
|
32317523 |
2020 |
5 |
The contribution of iron deficiency to the risk of peripartum transfusion: a retrospective case control study.
61
|
VanderMeulen H...Callum J
|
32252681 |
2020 |
6 |
Resolving Blocked Antigen Phenomenon in Hemolytic Disease of the Fetus and Newborn Due to Anti-K.
61
|
Moosavi M...McGonigle AM
|
32209273 |
2020 |
7 |
Next Generation Sequencing-Based Fetal ABO Blood Group Prediction by Analysis of Cell-Free DNA from Maternal Plasma.
61
|
Rieneck K...Dziegiel MH
|
32110193 |
2020 |
8 |
Potential of Next-Generation Sequencing in Noninvasive Fetal Molecular Blood Group Genotyping.
61
|
Wienzek-Lischka S...Bein G
|
32110190 |
2020 |
9 |
Fatal hemolytic disease of the fetus and newborn caused by anti-Jra antibody: A case report and literature review.
61
|
Kim MS...Oh HB
|
31324575 |
2020 |
10 |
Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies.
61
|
Koelewijn JM...de Haas M
|
31867744 |
2020 |
11 |
The use of IVIg in fetal and neonatal alloimmune thrombocytopenia- Principles and mechanisms.
61
|
Wabnitz H...Lazarus AH
|
31926738 |
2020 |
12 |
A case of mild HDFN caused by anti-C, anti-D, and anti-G: Diagnostic strategy and clinical significance of distinguishing anti-G from anti-D and anti-C.
61
|
Chen J...Liu F
|
31303507 |
2020 |
13 |
Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
61
|
Gudlaugsson B...Halldorsdottir AM
|
31850521 |
2020 |
14 |
Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis.
61
|
Xie X...Zhou D
|
32163467 |
2020 |
15 |
Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
61
|
Ree IMC...De Haas M
|
31978433 |
2020 |
16 |
Cold reacting anti-M causing delayed hemolytic disease of the newborn.
61
|
Crispin P...Sethna F
|
31670408 |
2019 |
17 |
Clinical approach after identification of a rare anti-Ena in a prenatal sample.
61
|
Howard P...George MR
|
31935334 |
2019 |
18 |
Acute hemolytic transfusion reaction associated with anti-Mta : case report and review of the literature.
61
|
Claes V...El Kenz H
|
31503331 |
2019 |
19 |
Coordinating Care Across the Perinatal Continuum in Hemolytic Disease of the Fetus and Newborn: The Timely Handoff of a Positive Maternal Anti-Erythrocyte Antibody Screen.
61
|
Vats K...Watchko JF
|
31451186 |
2019 |
20 |
The prenatal intervention of pregnancy complicated with anti-Kell isoimmunization: a review.
61
|
Sun JB
|
31571493 |
2019 |
21 |
Blood Donation During Pregnancy Due to Anti-Ku Hemolytic Disease of the Fetus and Newborn.
61
|
Virk M...Andrews J
|
31089725 |
2019 |
22 |
Amplicon Sequencing-Based Noninvasive Fetal Genotyping for RHD-Positive D Antigen-Negative Alleles.
61
|
Takahashi K...Hata K
|
31488553 |
2019 |
23 |
Conservative Management of Hyperferritinemia in Hemolytic Disease of the Fetus and Newborn: A Case Report and Review of the Literature.
61
|
Adam DL...Moorehead PC
|
31460887 |
2019 |
24 |
Anemic Disease of the Newborn With Little Increase in Hemolysis and Erythropoiesis Due to Maternal Anti-Jra: A Case Study and Review of the Literature.
61
|
Katsuragi S...Ikeda T
|
31227265 |
2019 |
25 |
Heat elution: a modification of the Landsteiner-Miller method.
61
|
Dean-El C...Quraishy N
|
31246486 |
2019 |
26 |
Prevention of hemolytic transfusion reactions with intravenous immunoglobulin prophylaxis in U- patients with anti-U.
61
|
Win N...Bullock T
|
30861151 |
2019 |
27 |
Transfusion-related red blood cell alloantibodies: induction and consequences.
61
|
Tormey CA...Hendrickson JE
|
30808636 |
2019 |
28 |
Molecular Detection of Glycophorins A and B Variant Phenotypes and their Clinical Relevance.
61
|
Hassan SN...Wan Ab Rahman WS
|
30910255 |
2019 |
29 |
Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn.
61
|
Leonard A...Webb J
|
30720868 |
2019 |
30 |
Severe Fetal Hemolysis and Cholestasis Due to High-Titer Maternal IgG Anti-A Antibodies.
61
|
Zonneveld R...Schonewille H
|
30872329 |
2019 |
31 |
Postponing early intrauterine transfusion with intravenous immunoglobulin treatment: the PETIT study on severe hemolytic disease of the fetus and newborn.
61
|
Maisonneuve E...Jouannic JM
|
30837065 |
2019 |
32 |
Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature.
61
|
Li S...Fang Q
|
30520533 |
2019 |
33 |
Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan.
61
|
Moinuddin I...Millward P
|
31692490 |
2019 |
34 |
Bombay phenotype (Oh ) and high-titer anti-H in pregnancy: two case reports and a review of the literature.
61
|
Bullock T...Mir N
|
30260479 |
2018 |
35 |
Sulfhydryl treatment of serum or plasma for the reduction of IgM antibodies.
61
|
Blagg LN
|
30624946 |
2018 |
36 |
The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2.
61
|
Lemay AS...Lau W
|
30299537 |
2018 |
37 |
Neonatal Alloimmune Neutropenia.
61
|
Porcelijn L...de Haas M
|
31049048 |
2018 |
38 |
Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31).
61
|
Turley E...Au N
|
30222865 |
2018 |
39 |
Red Blood Cell Alloimmunization in the Pregnant Patient.
61
|
Webb J...Delaney M
|
30097223 |
2018 |
40 |
Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
61
|
Slootweg YM...De Haas M
|
30063902 |
2018 |
41 |
Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
61
|
Zwiers C...de Haas M
|
29902448 |
2018 |
42 |
Determination of fetal RHD type in plasma of RhD negative pregnant women.
61
|
Sorensen K...Akkok CA
|
29869532 |
2018 |
43 |
Clinical significance of antibodies to antigens in the Raph, John Milton Hagen, I, Globoside, Gill, Rh-associated glycoprotein, FORS, JR, LAN, Vel, CD59, and Augustine blood group systems.
61
|
Moghaddam M...Naghi AA
|
30295501 |
2018 |
44 |
Clinical significance of antibodies to antigens in the Scianna, Dombrock, Colton, Landsteiner-Weiner, Chido/Rodgers, H, Kx, Cromer, Gerbich, Knops, Indian, and Ok blood group systems.
61
|
Crottet SL
|
30295505 |
2018 |
45 |
Frequency of Red Cell Alloantibodies in Pregnant Females of Navsari District: An Experience that Favours Inclusion of Screening for Irregular Erythrocyte Antibody in Routine Antenatal Testing Profile.
61
|
Kahar M
|
30065546 |
2018 |
46 |
Predicted S and s phenotypes from genotyping results among Thai populations to prevent transfusion-induced alloimmunization risks.
61
|
Nathalang O...Intharanut K
|
30078741 |
2018 |
47 |
ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.
61
|
Zwiers C...van der Schoot CE
|
29624682 |
2018 |
48 |
Transfusions of least-incompatible blood with intravenous immunoglobulin plus steroids cover in two patients with rare antibody.
61
|
Win N...Chang C
|
29732576 |
2018 |
49 |
Clinical significance of antibodies to antigens in the International Society of Blood Transfusion collections, 700 series of low-incidence antigens, and 901 series of high-incidence antigens.
61
|
Lomas-Francis C
|
29989417 |
2018 |
50 |
Molecular characterization and multidisciplinary management of Gerbich hemolytic disease of the newborn.
61
|
Levitt RN...Yang E
|
29469208 |
2018 |